Clinical Pharmacokinetics of the Anti-Interleukin-20 Monoclonal Antibody NNC0109-0012 in Healthy Volunteers and Patients with Psoriasis or Rheumatoid Arthritis

Conclusion The PK profile of NNC0109-0012 is similar to other monoclonal antibodies directed against soluble targets.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research